Michael Knaap resigns as CEO of Australia's Monash IVF
June 12 (Reuters) - Australian fertility business Monash IVF (MVF.AX), opens new tab said on Thursday its chief executive officer and managing director, Michael Knaap, had resigned.
The news comes days after the firm reported a second fertility clinic mix-up over a span of two months, raising concerns around an industry that did not have much active government attention until recently.
The IVF provider's finance chief, Malik Jainudeen, has taken over as acting CEO.
The company did not give out a reason behind Knaap's resignation and it did not immediately respond to a Reuters request for comment.
He previously served as Monash CFO for over three years and took over the CEO role in April 2019.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mail
2 hours ago
- Daily Mail
Anthony Albanese yet to secure crunch meeting with Donald Trump as he jets off to meet other world leaders
Anthony Albanese is jetting off abroad to meet other world leaders, yet has been criticised for failing to secure an official meeting with Donald Trump as the US administration applies pressure on Australia's defence spending. The Prime Minister will leave Canberra on Friday to meet his 'dear friend', the Prime minister of Fiji, Sitiveni Rabuka, before then travelling on to Seattle for a meeting of world business leaders. His next stop will be the G7 summit in the mountainous Canadian town of Kananaskis where Albanese will cross paths with the US President, just days after the Pentagon announced it was launching a review into the $368bn AUKUS submarine deal. 'I look forward to working productively with world leaders to discuss how we tackle some of the most challenging issues facing Australia, our region, and the world,' Albanese said. But the Opposition has been critical of his inability to lock in a meeting with Trump, at time when the AUKUS deal hangs in the balance and Australia is facing punitive tariffs. It also comes at a time when the US President has put pressure on Australia to increase its defence spending to 3.5 per cent of GDP - up from the current rate of around 2.3 per cent. Albanese has spoken over the phone twice to President Trump since he was re-elected in November last year but the pair are yet to have a face-to-face meeting. Opposition Leader Sussan Ley said on Friday morning she was 'concerned' about the US review into the AUKUS deal by Defence Under Secretary for Policy, Elbridge Colby, who she claimed was a 'a sceptic of AUKUS'. Under the $368 billion submarine program, Australia is set to acquire at least three nuclear-powered Virginia-class boats from the US in the early 2030s before a new fleet is built for delivery from the 2040s. The pact between Australia, the US, and the UK is aimed at countering China's expanding presence in the Indo-Pacific. But the Pentagon review will assess whether the deal meets Trump's 'America First' objective. Ley acknowledged that it was 'really hard' to secure a meeting with the US President, but she insisted Albanese had to have a face-to-face meeting. 'Lots of other world leaders have had that meeting. We haven't,' Ley told KIIS FM. However, Trump is yet to lock in any meetings with other world leaders, The Australian reported. The G7 brings together seven of the world's largest advanced economies – Canada, France, Germany, Italy, Japan, the United Kingdom and the United States – and the European Union. Climate and security are expected to dominate the diplomatic talks between leaders. Australia is not a member of the G7, but Canadian prime minister Mark Carney extended an invitation to Albanese. He is expected to meet with the US president on the sidelines of the conference, where he could try to carve out a tariff exemption. Australia is facing 10 per cent tariffs on goods exported to the US and - like every US trading partner except the UK - has been hit with 50 per cent tariffs on aluminium and steel sent to America. The Australian government has called the trade measures an 'act of economic self-harm' and is considering using critical minerals and US beef imports as bargaining chips. Albanese has not yet confirmed whether he will meet with Trump, though other bilateral discussions have been organised with the leaders of Canada, the UK, South Korea and Japan.
Reuters
2 hours ago
- Reuters
Thermo Fisher plans to sell parts of diagnostics unit for $4 billion, FT reports
June 12 (Reuters) - Thermo Fisher Scientific (TMO.N), opens new tab plans to sell its diagnostics unit for about $4 billion in an attempt to offload some of its low-growth assets, the Financial Times reported on Thursday, citing people familiar with the matter. The contract drug manufacturer recently enlisted advisers to explore private equity interest in part of its diagnostics business, including its microbiology unit, which produces infectious disease testing equipment, according to the Financial Times. The auction process does not guarantee a sale, the report said, adding that Thermo Fisher may decide to retain the asset. Thermo Fisher did not immediately respond to a Reuters' request for comment. In February, the company acquired Solventum's purification and filtration business for about $4.1 billion in cash.
Reuters
4 hours ago
- Reuters
New Zealand manufacturing contracts in May amid economic uncertainties
SYDNEY, June 13 (Reuters) - Manufacturing activity in New Zealand fell back into contraction in May, after four straight months of expansion, because of weak demand, rising costs and low business confidence amid global economic uncertainties, a survey showed on Friday. The Bank of New Zealand-Business NZ's seasonally adjusted Performance of Manufacturing Index (PMI) dipped to 47.5 from a revised 53.3 in April. New orders slumped to 45.3 from a revised 50.8 in the prior month. A reading above 50 indicates manufacturing activity is expanding, while anything below that threshold points to contraction. "The New Zealand economy can claw its way forward over the course of 2025, but the PMI is yet another indicator that suggests an increased risk that the bounce in GDP ... could come to a grinding halt," BNZ Senior Economist Doug Steel said.
